In a field with varied patient experiences, a wide variety of treatment options available, and evolving clinical science and techniques, Boston Scientific needed to find a creative way to differentiate and promote its products for addressing Benign Prostatic Hyperplasia (BPH) among treating physicians. Merryman Communications partnered with the company to create an award-winning, first and only comprehensive platform that provides physicians with credible and actionable peer-to-peer insights to advance the treatment of BPH.